New stain may help doctors spot hidden cancer cells during skin surgery
NCT ID NCT07258446
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tests whether adding a special stain (PRAME) to standard microscope checks during Mohs surgery helps doctors see leftover melanoma cells more clearly. About 36 adults with early-stage melanoma (stage 0 to IIc) will take part. The goal is to see if the stain improves accuracy in deciding when all cancer has been removed, potentially reducing the need for repeat surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I CUTANEOUS MELANOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.